Tiziana life sciences ltd. to implement stock repurchase program for up to $5 million

New york, jan. 24, 2022 (globe newswire) -- tiziana life sciences ltd. (nasdaq: tlsa) announced that its board of directors has today authorized the company's management to implement a stock repurchase program for up to $5 million of the company's common shares at any time. the term of the board authorization is until december 31, 2022. the repurchase program may be suspended or discontinued at any time and will be funded using the company's working capital.
TLSA Ratings Summary
TLSA Quant Ranking